Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment Newswire.ca - Thu Dec 26, 2024

/CNW/ -- USA News Group News Commentary – Immunotherapy is transforming oncology by harnessing the immune system's power to fight cancer like never before....

ALLO : 1.95 (-5.34%)
ONCY : 0.8210 (-5.59%)
CNTX : 1.0300 (-4.63%)
RXRX : 6.46 (-6.10%)
ONC.TO : 1.21 (-3.20%)
ERAS : 2.05 (-13.50%)
The Immunotherapy Boom: What It Means for the Future of Cancer Treatment BayStreet.ca - Thu Dec 26, 2024

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Immunotherapy is revolutionizing oncology by harnessing the power of the immune system to fight cancer...

ONCY : 0.8210 (-5.59%)
AUTL : 2.24 (-5.08%)
IOVA : 5.95 (-7.03%)
ABBV : 177.44 (+1.30%)
ONC.TO : 1.21 (-3.20%)
IBRX : 2.42 (+0.21%)
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook FinancialNewsMedia - Thu Dec 26, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END

ONCY : 0.8210 (-5.59%)
AZN : 66.06 (-1.42%)
ABBV : 177.44 (+1.30%)
ONC.TO : 1.21 (-3.20%)
GSK : 32.67 (-1.27%)
CRDF : 3.42 (-5.26%)
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data FinancialNewsMedia - Thu Dec 26, 2024

Promising BRACELET-1 results in HR+/HER2- metastatic breast cancer lay the foundation for potential registration-enabling study and accelerated approval   Advancing gastrointestinal cancer pipeline underscores...

ONCY : 0.8210 (-5.59%)
ONC.TO : 1.21 (-3.20%)
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options Newswire.ca - Mon Dec 23, 2024

/CNW/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies...

ONCY : 0.8210 (-5.59%)
RPTX : 1.3450 (-2.54%)
IMRX : 1.97 (-4.83%)
ONC.TO : 1.21 (-3.20%)
RNXT : 1.2600 (-5.26%)
CRGX : 12.31 (-8.81%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Mon Dec 23, 2024

Is providing a recap of the major accomplishments from 2024 and a preview of the milestones that are ...

BLX.TO : 25.95 (-2.00%)
ONC.TO : 1.21 (-3.20%)
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data Newswire.ca - Mon Dec 23, 2024

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, is providing a recap...

ONCY : 0.8210 (-5.59%)
ONC.TO : 1.21 (-3.20%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses FinancialNewsMedia - Fri Dec 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.8210 (-5.59%)
CKPT : 3.17 (+0.32%)
PSNL : 5.33 (-4.65%)
ONC.TO : 1.21 (-3.20%)
TEM : 33.71 (-10.15%)
CRDF : 3.42 (-5.26%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses Newswire.ca - Fri Dec 20, 2024

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.8210 (-5.59%)
CKPT : 3.17 (+0.32%)
PSNL : 5.33 (-4.65%)
ONC.TO : 1.21 (-3.20%)
TEM : 33.71 (-10.15%)
CRDF : 3.42 (-5.26%)
From Crisis to Opportunity: How Advances in Immunotherapy Are Shaping the Oncology Sector BayStreet.ca - Thu Dec 19, 2024

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite significant advances in oncology research, challenges remain as the American Cancer Society...

ONCY : 0.8210 (-5.59%)
PYXS : 1.4950 (-3.55%)
RPTX : 1.3450 (-2.54%)
IMRX : 1.97 (-4.83%)
CVM : 0.3998 (-5.97%)
ONC.TO : 1.21 (-3.20%)

Barchart Exclusives

This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025. Barchart - 26 minutes ago
With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot